GP financing explained: how managers borrow against fees and carry
Alex Branton's explainer for Not Very Private Equity on what GP financing is, what secures it, why banks struggle with it, and why facilities below $30m are hard to find.

Nodem's Alex Branton has written an explainer on GP financing for Not Very Private Equity, published on 13 October 2026. The piece covers what the product is, what a lender takes as security, why banks struggle to offer it, and why managers raising funds below about $400m find so few options.
Read the full article: GP financing, explained. How managers borrow against fees and carry, and why it is so hard to find below $30m (link: https://www.notveryprivateequity.com/gp-financing-explained-how-managers-borrow-against-fees-and-carry-and-why-it-is-so-hard-to-find-below-30m/)
What the article covers
GP financing is a loan or preferred instrument made at the manager level, to the general partner, the management company or a sponsor affiliate, rather than to the fund. Repayment comes from management fees and carried interest. No fund assets and no LP commitments are pledged.
The article sets out the five things managers use it for: funding the GP commitment to a new fund, which institutional LPs typically expect to be 2% to 5% of the raise; bridging capital calls and co-investment obligations; funding management company growth; succession, such as a founder buying out a retiring partner; and advancing a conservative portion of accrued carry where the fund terms allow it.
What secures a GP loan
Security is taken in layers: management company equity and receivables, an assignment of management fee rights with a controlled account and a reserve, funded interests in prior funds, and carried interest where vesting and clawback terms permit. Nodem writes these facilities at $10m to $100m+, priced at a margin over SOFR or SONIA, cash-pay or PIK, over two to seven years.
Why banks find it hard, and why there is almost no market below $30m
Bank models favour durable, hard-asset cash flows. GP cash flow is concentrated, steps down after the investment period and depends on unrealised value. The article describes the three patterns managers meet as a result: the relationship toll, bundling with a fund-level subscription line, and the slow yes that arrives after the capital call deadline.
Below $30m the market thins out because the large GP stakes platforms target established managers with bigger tickets, and because the diligence cost of a GP facility does not shrink with its size. A manager making a $15m commitment to a $400m fund has a short list: a few specialist lenders, family offices, or the partners' own balance sheets.
Six questions for any lender
The piece closes with the questions a GP should put to any lender before signing: what is pledged and whether it reaches the fund; whether a fund-level product is required alongside; recourse and personal guarantees; how carry triggers work; the all-in cost including PIK; and what the balance looks like at maturity if exits are late and carry is zero.